Nasdaq5d
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Nasdaq3d
Novavax (NVAX) Stock Dips While Market Gains: Key Facts
Novavax (NVAX) closed at $7.91 in the latest ... On the other hand, the Dow registered a gain of 0.92%, and the technology-centric Nasdaq increased by 1.41%. Shares of the vaccine maker have ...
Bank of New York Mellon Corp Increases Position in Novavax, Inc. (NASDAQ:NVAX)
Bank of New York Mellon Corp lifted its stake in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 0.4% during the ...
Novavax Inc. stock underperforms Friday when compared to competitors
Shares of Novavax Inc. NVAX slipped 1.55% to $7.60 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.52% to 17,784.05 ...
Nasdaq7d
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying
Novavax performed well last year ... the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and Tom ...
Nasdaq11d
Novavax Appoints Margaret McGlynn To Succeed James Young As Chair Of The Board
(RTTNews) - Novavax, Inc. (NVAX ... the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with ...
ETF Daily News5d
Wealthfront Advisers LLC Makes New Investment in Novavax, Inc. (NASDAQ:NVAX)
Wealthfront Advisers LLC purchased a new position in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC.
Novavax, Inc. (NASDAQ:NVAX) Receives $18.00 Average Price Target from Analysts
Novavax, Inc. (NASDAQ:NVAX – Get Free Report) has earned an average recommendation of “Hold” from the seven brokerages that are covering the firm, MarketBeat.com reports. One equities research analyst ...
Former Texas congressman Burgess eyed as CDC director nominee - report
The White House is reportedly considering former U.S. Rep. Michael Burgess (R-Texas) as its nominee to head the CDC. Burgess, ...
Zacks.com on MSN3d
Novavax (NVAX) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Novavax (NVAX) stood at $7.91, denoting a -0.57% change from the preceding trading day.
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying
Buying stocks after they have lost significant market value can lead to excellent returns in the long run, but only if the ...
Novavax Inc. stock underperforms Thursday when compared to competitors
Shares of Novavax Inc. NVAX shed 2.40% to $7.72 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.33% to 17,691.63 ...